Co-Authors
                            
                            
                                This is a "connection" page, showing publications co-authored by   ANDRAS HECZEY   and   PAVEL SUMAZIN.
                            
                            
                            
                                
                                    
                                            
    
        
        
        
            Connection Strength
            
                
            
            1.381
         
        
        
     
 
    
        
        - 
            Coordinated regulation by lncRNAs results in tight lncRNA-target couplings. Cell Genom. 2025 Aug 13; 5(8):100927.
            
            
                Score: 0.245
             
- 
            Asynchronous Transitions from Hepatoblastoma to Carcinoma in High-Risk Pediatric Tumors. bioRxiv. 2024 Dec 27.
            
            
                Score: 0.236
             
- 
            Interleukin-15-armoured GPC3 CAR T cells for patients with solid cancers. Nature. 2025 Jan; 637(8047):940-946.
            
            
                Score: 0.235
             
- 
            Interleukin-15-armored GPC3-CAR T cells for patients with solid cancers. Res Sq. 2024 Apr 03.
            
            
                Score: 0.224
             
- 
            Hepatoblastomas with carcinoma features represent a biological spectrum of aggressive neoplasms in children and young adults. J Hepatol. 2022 10; 77(4):1026-1037.
            
            
                Score: 0.197
             
- 
            Genomic analysis of hepatoblastoma identifies distinct molecular and prognostic subgroups. Hepatology. 2017 01; 65(1):104-121.
            
            
                Score: 0.135
             
- 
            A novel treatment strategy utilizing panobinostat for high-risk and treatment-refractory hepatoblastoma. J Hepatol. 2024 04; 80(4):610-621.
            
            
                Score: 0.055
             
- 
            Navigating relapsed hepatoblastoma: Predictive factors and surgical treatment strategy. Cancer Med. 2023 12; 12(23):21270-21278.
            
            
                Score: 0.055